Ignite Creation Date:
2025-12-24 @ 7:18 PM
Ignite Modification Date:
2026-05-13 @ 4:55 AM
Study NCT ID:
NCT06383403
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-04
First Post:
2024-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.
Sponsor:
Ipsen
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Primary Biliary Cholangitis | View |
Keywords: